Recruiting
Phase 2

A Study Evaluating APG777 in Atopic Dermatitis

Sponsor:

Apogee Therapeutics, Inc.

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information